Basic Information
Mymetics Corporation is a Switzerland-based biotechnology company with a research laboratory in the Netherlands, focusing on the development of next-generation vaccines for the prevention of infectious and debilitating diseases. The organization is currently developing several vaccines, including those for Covid-19, HIV-1/AIDS, and malaria. Mymetics' core technology and expertise lie in the use of virosomes, lipid carriers containing functional fusion viral proteins and natural membrane proteins, as well as rationally designed antigens.
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios

